経皮ドラッグデリバリーシステムの市場規模、シェア、動向分析レポート：技術別、用途別、地域別、セグメント予測、2024年～2030年

経皮ドラッグデリバリーシステム市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、経皮ドラッグデリバリーシステムの世界市場規模は、CAGR 11.9%で拡大し、2030年までに1,450億4,000万米ドルに達すると予測されています。

経皮パッチの受け入れ拡大、特に一貫した毎日のインスリン投与が必要な糖尿病のような症状に対する受け入れ拡大が、経皮ドラッグデリバリーシステム分野の市場成長を促進すると予測されています。

さらに、糖尿病患者は定期的なインスリン投与を必要とするが、従来は注射によって行われていたため、不快感が生じたり、病気感染のリスクが高まったりする可能性があります。このため、経皮ドラッグデリバリーシステムは、インスリンをデリバリーするための、より魅力的な選択肢となると思われます。市場成長に寄与するもう一つの重要な要因は、痛みのないドラッグデリバリーに対する需要の高まりです。インスリン投与のために常に注射を使用することは、不快感や慢性疾患につながる可能性があります。経皮パッチは、より快適で効率的なインスリン送達方法を提供するため、これらの問題に対処します。

さらに、糖尿病、心臓病、疼痛関連問題などの慢性疾患が世界的に一般的になるにつれ、効果的で患者にとって使いやすいドラッグデリバリー方法の必要性が高まっています。例えば、米国心臓協会の2022年版世界疾病負担報告書によると、人口10万人当たりの死亡率は239.8、有病率は7354.1でした。経皮ドラッグデリバリーシステムには、非侵襲性、薬物放出の制御、患者のアドヒアランス向上、副作用の最小化など、複数の利点があります。このようなユーザーフレンドリーなドラッグデリバリーシステム、特に長期投薬の継続管理に対する需要の高まりが、経皮ドラッグデリバリー市場の成長を促進しています。

経皮ドラッグデリバリーシステム市場レポートハイライト：

• 2023年には、イオントフォレーシス分野が最大の市場シェアを占めました。これは、電流を用いて皮膚から非侵襲的に薬剤を送達する有効性によるものと考えられます。
• 2023年には、関節炎、変形性関節症、整形外科的変性疾患などの筋骨格系障害を含む慢性疾患や外傷の有病率の増加により、疼痛管理分野が用途別セグメントをリードしました。これらの疾患の有病率の増加が寄与し、同分野の成長を牽引しています。
• ホルモンセグメントは、2023年の用途セグメントにおいて、予測期間中に指数関数的なCAGRで成長すると予想されています。これは、簡便なホルモン療法に対する需要の高まりによるものです。経皮投与の有効性と使いやすさは、ホルモン投与の魅力的なソリューションとなっています。
• 北米地域は、高度なヘルスケアインフラと慢性疼痛、中枢神経系障害、心血管疾患などの対象疾患の高い有病率により、2023年に最大の市場シェアを占めました。
• 市場プレーヤーは、製品リーチを拡大し、多様な地域での可用性を向上させるためにいくつかの戦略的イニシアチブを採用しています。

目次

第1章 経皮ドラッグデリバリーシステム市場：調査手法と範囲

第2章 経皮ドラッグデリバリーシステム市場：エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し
• 競合考察

第3章 経皮ドラッグデリバリーシステム市場：変数、動向、範囲

• 市場系統の見通し
• 市場力学
• 経皮ドラッグドラッグデリバリーシステム市場分析ツール

第4章 経皮ドラッグデリバリーシステム市場：技術推定・動向分析

• 定義と範囲
• テクノロジー市場シェア、2023年と2030年
• セグメントダッシュボード
• 技術展望別の世界の経皮ドラッグデリバリーシステム市場
• 市場用途と予測および動向分析、2018年から2030年まで

第5章 経皮ドラッグデリバリーシステム市場：用途の推定・動向分析

• 定義と範囲
• 用途市場シェア、2023年と2030年
• セグメントダッシュボード
• 用途別の世界の経皮ドラッグデリバリーシステム市場の見通し
• 市場用途と予測および動向分析、2018年から2030年まで

第6章 経皮ドラッグデリバリーシステム市場：地域推定・動向分析

• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 市場規模と予測トレンド分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
  • イノベーター
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2023
  • Novartis AG
  • Johnson &Johnson
  • Mylan Pharmaceuticals, Inc.
  • Boehringer Ingelheim GmbH
  • AbbVie
  • Grunenthal
  • Skyepharma
  • 3M Company
  • Noven Pharmaceuticals, Inc.
  • 4P Therapeutics, LLC
  • Hisamitsu Pharmaceutical co. Inc

List of Tables

• Table 1. List of secondary sources
• Table 2. List of Abbreviation
• Table 3. North America transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
• Table 4. North America transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 5. North America transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 6. U.S. transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 7. U.S. transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 8. Canada transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 9. Canada transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 10. Europe transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
• Table 11. Europe transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 12. Europe transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 13. Germany transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 14. Germany transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 15. UK transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 16. UK transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 17. France transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 18. France transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 19. Italy transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 20. Italy transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 21. Spain transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 22. Spain transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 23. Denmark transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 24. Denmark transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 25. Sweden transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 26. Sweden transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 27. Norway transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 28. Norway transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 29. APAC transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
• Table 30. APAC transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 31. APAC transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 32. Japan transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 33. Japan transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 34. India transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 35. India transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 36. China transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 37. China transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 38. South Korea transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 39. South Korea transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 40. Thailand transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 41. Thailand transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 42. Australia transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 43. Australia transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 44. Latin America transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
• Table 45. Latin America transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 46. Latin America transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 47. Brazil transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 48. Brazil transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 49. Mexico transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 50. Mexico transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 51. Argentina transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 52. Argentina transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 53. Middle East and Africa transdermal drug delivery system market, by region, 2018 - 2030 (USD Million)
• Table 54. Middle East and Africa transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 55. Middle East and Africa transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 56. South Africa transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 57. South Africa transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 58. Saudi Arabia transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 59. Saudi Arabia transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 60. UAE transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 61. UAE transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)
• Table 62. Kuwait transdermal drug delivery system market, by technology, 2018 - 2030 (USD Million)
• Table 63. Kuwait transdermal drug delivery system market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig 1. Transdermal drug delivery system segmentation
• Fig 2. Market research process
• Fig 3. Information procurement process
• Fig 4. Primary research pattern
• Fig 5. Transdermal drug delivery system snapshot, 2023 (USD Million)
• Fig 6. Segment snapshot, USD Million
• Fig 7. Competitive landscape snapshot
• Fig 8. Penetration & growth prospect mapping, by product
• Fig 9. Market driver analysis (Current & future impact)
• Fig 10. Market restraint analysis (Current & future impact)
• Fig 11. Transdermal drug delivery system market, technology outlook key takeaways (USD Million)
• Fig 12. Transdermal drug delivery system: technology movement analysis (USD Million), 2023 & 2030
• Fig 13. Electroporation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 14. Radio frequency market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 15. Iontophoresis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 16. Microporation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 17. Thermal market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 18. Mechanical arrays market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 19. Ultrasound market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 20. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 21. Transdermal drug delivery systems market: application movement analysis (USD Million), 2023 & 2030
• Fig 22. CNS market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 23. Pain Management market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 24. Cardiovascular market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 25. Hormone market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 26. Immunological market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 27. Metabolic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 28. Gastrointestinal market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 29. Infection market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 30. Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 31. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 32. Transdermal drug delivery system market: Regional key takeaways (USD Million)
• Fig 33. Transdermal drug delivery system market: Regional outlook, 2023 & 2030, USD Million
• Fig 34. North America transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 35. U.S. transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 36. Canada transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 37. Europe transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 38. UK transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 39. Germany transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 40. France transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 41. Spain transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 42. Italy transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 43. Sweden transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 44. Norway transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 45. Denmark transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 46. Asia Pacific transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 47. China transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 48. Japan transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 49. India transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 50. South Korea transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 51. Australia transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 52. Thailand transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 53. Latin America transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 54. Brazil transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 55. Mexico transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 56. Argentina transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 57. Middle East and Africa transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 58. South Africa transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 59. Saudi Arabia transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 60. UAE transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 61. Kuwait transdermal drug delivery system market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig 62. List of key emerging company's/technology disruptors/innovators

Transdermal Drug Delivery Systems Market Growth & Trends:

The global transdermal drug delivery systems market size is anticipated to reach to reach USD 145.04 billion by 2030, expanding at a CAGR of 11.9%, based on a new report by Grand View Research, Inc. The growing acceptance of transdermal patches, particularly for conditions like diabetes that necessitate consistent and daily insulin dosage, is projected to drive market growth in the transdermal drug delivery systems sector.

In addition, diabetes patients require regular insulin administration, traditionally done through injections, which can cause discomfort and increase the risk of disease transmission. This makes transdermal drug delivery system will be a more appealing alternative for delivering insulin.Another significant factor contributing to the growth of the market is the rising demand for painless drug delivery. The constant use of injections for insulin administration can lead to discomfort and even chronic diseases. Transdermal patches offer a more comfortable and efficient way of delivering insulin, thus addressing these issues.

Moreover, chronic diseases like diabetes, heart conditions, and pain-related issues become more common globally, there is a greater need for drug delivery methods that are both effective and easy for patients to use. For example, according to the American Heart Association's 2022 report on the Global Burden of Disease, the death rate per 100,000 people was 239.8, while the prevalence rate was 7354.1 per 100,000. Transdermal drug delivery systems come with multiple benefits such as being non-invasive, providing controlled drug release, enhancing patient adherence, and minimizing side effects. This increasing demand for user-friendly drug delivery systems, particularly for the ongoing management of long-term medications, is driving the transdermal drug delivery market growth.

Transdermal Drug Delivery Systems Market Report Highlights:

• In 2023, the iontophoresis segment accounted for the largest market share. This can be attributed due to its effectiveness in delivering medications non-invasively through the skin using electrical currents
• In 2023, the pain management segment led the application segment due to the increasing prevalence of chronic diseases and trauma, including musculoskeletal disorders such as arthritis, osteoarthritis, and orthopedic degenerative disorders. The growing prevalence of these conditions is contributing, driving the segment growth
• The hormone segment is expected to grow at an exponential CAGR during the forecast period in the application segment in 2023. This is due to rising demand for convenient hormone therapies. Transdermal delivery's effectiveness and user-friendliness make it an attractive solution for administering hormones
• The North American region held the largest market share in 2023 due to advanced healthcare infrastructure and high prevalence of targeted diseases like chronic pain, central nervous system disorders, and cardiovascular diseases in the region
• Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas

Table of Contents

Chapter 1. Transdermal Drug Delivery Systems Market: Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Technology
  • 1.1.2. Application
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Transdermal Drug Delivery Systems Market: Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology outlook
  • 2.2.2. Application outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Transdermal Drug Delivery Systems Market: Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing adoption of transdermal patches
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. High demand for pain free drug delivery
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of transdermal technology
    • 3.2.2.2. Limited number of approved medications
• 3.3. Transdermal Drug Delivery System Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Transdermal Drug Delivery Systems Market: Technology Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Electroporation
  • 4.1.2. Radio Frequency
  • 4.1.3. Iontophoresis
  • 4.1.4. Microporation
  • 4.1.5. Thermal
  • 4.1.6. Mechanical arrays
  • 4.1.7. Ultrasound
  • 4.1.8. Others
• 4.2. Technology Market Share, 2023 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Transdermal Drug Delivery System Market by Technology Outlook
• 4.5. Market Application & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Electroporation
    • 4.5.1.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
  • 4.5.2. Radio Frequency
    • 4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 4.5.3. Iontophoresis
    • 4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 4.5.4. Microporation
    • 4.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 4.5.5. Thermal
    • 4.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 4.5.6. Mechanical Arrays
    • 4.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 4.5.7. Ultrasound
    • 4.5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 4.5.8. Others
    • 4.5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)

Chapter 5. Transdermal Drug Delivery System Market: Application Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. CNS
  • 5.1.2. Pain Management
  • 5.1.3. Cardiovascular
  • 5.1.4. Hormone
  • 5.1.5. Immunological
  • 5.1.6. Metabolic
  • 5.1.7. Gastrointestinal
  • 5.1.8. Infection
  • 5.1.9. Cancer
  • 5.1.10. Others
• 5.2. Application Market Share, 2023 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Transdermal Drug Delivery System Market by Application Outlook
• 5.5. Market Application & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. CNS
    • 5.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.5.2. Pain Management
    • 5.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.5.3. Cardiovascular
    • 5.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.5.4. Hormone
    • 5.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.5.5. Immunological
    • 5.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.5.6. Metabolic
    • 5.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.5.7. Gastrointestinal
    • 5.5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.5.8. Infection
    • 5.5.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.5.9. Cancer
    • 5.5.9.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
  • 5.5.10. Others
    • 5.5.10.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)

Chapter 6. Transdermal Drug Delivery System Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Competitive scenario
    • 6.5.1.3. Regulatory framework
    • 6.5.1.4. Reimbursement scenario
    • 6.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Competitive scenario
    • 6.6.1.3. Regulatory framework
    • 6.6.1.4. Reimbursement scenario
    • 6.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Competitive scenario
    • 6.6.3.3. Regulatory framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Competitive scenario
    • 6.6.4.3. Regulatory framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Competitive scenario
    • 6.6.5.3. Regulatory framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Competitive scenario
    • 6.6.6.3. Regulatory framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Competitive scenario
    • 6.6.7.3. Regulatory framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Competitive scenario
    • 6.6.8.3. Regulatory framework
    • 6.6.8.4. Reimbursement scenario
    • 6.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Competitive scenario
    • 6.7.1.3. Regulatory framework
    • 6.7.1.4. Reimbursement scenario
    • 6.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Competitive scenario
    • 6.7.5.3. Regulatory framework
    • 6.7.5.4. Reimbursement scenario
    • 6.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Competitive scenario
    • 6.7.6.3. Regulatory framework
    • 6.7.6.4. Reimbursement scenario
    • 6.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Competitive scenario
    • 6.8.1.3. Regulatory framework
    • 6.8.1.4. Reimbursement scenario
    • 6.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.8.2. Mexico
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Competitive scenario
    • 6.8.2.3. Regulatory framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Competitive scenario
    • 6.8.3.3. Regulatory framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Competitive scenario
    • 6.9.1.3. Regulatory framework
    • 6.9.1.4. Reimbursement scenario
    • 6.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Competitive scenario
    • 6.9.2.3. Regulatory framework
    • 6.9.2.4. Reimbursement scenario
    • 6.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Competitive scenario
    • 6.9.3.3. Regulatory framework
    • 6.9.3.4. Reimbursement scenario
    • 6.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Competitive scenario
    • 6.9.4.3. Regulatory framework
    • 6.9.4.4. Reimbursement scenario
    • 6.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. Novartis AG
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Johnson & Johnson
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Mylan Pharmaceuticals, Inc.
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Boehringer Ingelheim GmbH
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. AbbVie
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Grunenthal
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Skyepharma
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. 3M Company
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Noven Pharmaceuticals, Inc.
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. 4P Therapeutics, LLC
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. Hisamitsu Pharmaceutical co. Inc
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Product benchmarking
    • 7.3.14.4. Strategic initiatives